Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$653.09+4.89 (+0.75%)
Close on Nov 17, 2026Market cap $18.27BP/E 36.2Yield –
Medpace enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Medpace's enterprise value was $18.05B on Nov 11, 2026, against $16.40B a year earlier. Over the last 5 years it ranged from $4.35B to $18.05B, with a median of $9.31B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $18.05B | +16.2% |
| 2025 | Dec 31, 2025 | $15.54B | +60.7% |
| 2024 | Dec 31, 2024 | $9.67B | +3.9% |
| 2023 | Dec 29, 2023 | $9.31B | +38.7% |
| 2022 | Dec 30, 2022 | $6.71B | -9.6% |
| 2021 | Dec 31, 2021 | $7.42B | +56.0% |
| 2020 | Dec 31, 2020 | $4.76B | +61.4% |
| 2019 | Dec 31, 2019 | $2.95B | +49.3% |
| 2018 | Dec 31, 2018 | $1.98B | +30.2% |
| 2017 | Dec 29, 2017 | $1.52B | -5.5% |
| 2016 | Dec 30, 2016 | $1.61B | – |
See a number that looks wrong?